By exploring the molecular mechanism of STAT3‐FOXO3 signaling axis, the novel cell‐free therapeutic product, EXO‐PD‐L1‐HGF‐activated endogenous nestin+ NPCs, might augment neurological functional recovery post‐stroke. Here, HGF is linked to stroke disorder.